E. Scardino

536 total citations
29 papers, 373 citations indexed

About

E. Scardino is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, E. Scardino has authored 29 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 11 papers in Oncology. Recurrent topics in E. Scardino's work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). E. Scardino is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). E. Scardino collaborates with scholars based in Italy, Austria and United States. E. Scardino's co-authors include Ottavio De Cobelli, Bernardo Rocco, Fabrizio Verweij, Sandro Barni, Giulia Villa, Giuseppe Renne, Gabriele Tancini, Paolo Lissoni, Antonio Ardizzoia and Deliu Victor Matei and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Urology.

In The Last Decade

E. Scardino

26 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Scardino Italy 11 172 150 84 83 68 29 373
Narihiko Hayashi Japan 14 352 2.0× 136 0.9× 68 0.8× 138 1.7× 77 1.1× 45 582
Tetsuya Imao Japan 13 187 1.1× 99 0.7× 54 0.6× 90 1.1× 58 0.9× 40 470
William R. Morgan United States 11 466 2.7× 177 1.2× 92 1.1× 39 0.5× 71 1.0× 15 637
G. Byron Hodge United States 7 124 0.7× 115 0.8× 45 0.5× 27 0.3× 31 0.5× 9 355
P.T. Scardino United States 8 150 0.9× 84 0.6× 35 0.4× 41 0.5× 16 0.2× 20 313
Bruce Malkowicz United States 13 271 1.6× 82 0.5× 51 0.6× 35 0.4× 88 1.3× 25 422
Shoko Takano Japan 10 87 0.5× 73 0.5× 67 0.8× 85 1.0× 5 0.1× 32 360
Soichiro Ogawa Japan 13 156 0.9× 62 0.4× 70 0.8× 59 0.7× 83 1.2× 47 440
Abby Hollander United States 11 120 0.7× 80 0.5× 28 0.3× 16 0.2× 22 0.3× 18 425
R. Sauer Germany 9 119 0.7× 162 1.1× 9 0.1× 239 2.9× 22 0.3× 18 467

Countries citing papers authored by E. Scardino

Since Specialization
Citations

This map shows the geographic impact of E. Scardino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Scardino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Scardino more than expected).

Fields of papers citing papers by E. Scardino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Scardino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Scardino. The network helps show where E. Scardino may publish in the future.

Co-authorship network of co-authors of E. Scardino

This figure shows the co-authorship network connecting the top 25 collaborators of E. Scardino. A scholar is included among the top collaborators of E. Scardino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Scardino. E. Scardino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jereczek‐Fossa, Barbara Alicja, Dario Zerini, Cristiana Fodor, et al.. (2010). Correlation Between Acute and Late Toxicity in 973 Prostate Cancer Patients Treated With Three-Dimensional Conformal External Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 78(1). 26–34. 47 indexed citations
2.
Spitaleri, Giosafat, Deliu Victor Matei, Giuseppe Curigliano, et al.. (2009). Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer. Annals of Oncology. 20(3). 498–502. 8 indexed citations
3.
Zerini, Dario, Cristiana Fodor, L. Santoro, et al.. (2009). 748 CORRELATION BETWEEN ACUTE AND LATE TOXICITY IN 973 PROSTATE CANCER PATIENTS TREATED WITH RADICAL OR POSTPROSTATECTOMY EXTERNAL BEAM IRRADIATION. European Urology Supplements. 8(4). 307–307. 1 indexed citations
4.
Curigliano, Giuseppe, Gianluca Spitaleri, Ottavio De Cobelli, et al.. (2009). Health-Related Quality of Life in Patients with Hormone Refractory Prostate Cancer Receiving Gefitinib. Urologia Internationalis. 82(2). 196–202. 4 indexed citations
5.
Petralia, Giuseppe, Giulia Villa, E. Scardino, et al.. (2008). Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. La radiologia medica. 113(4). 517–528. 35 indexed citations
6.
Curigliano, Giuseppe, Filippo de Braud, Maria Teresa Sandri, et al.. (2007). Gefitinib combined with endocrine manipulation in patients with hormone-refractory prostate cancer: quality of life and surrogate markers of activity. Anti-Cancer Drugs. 18(8). 949–954. 10 indexed citations
7.
Orecchia, Roberto, Barbara Alicja Jereczek‐Fossa, Mario Ciocca, et al.. (2007). Intraoperative radiotherapy for locally advanced prostate cancer: treatment technique and ultrasound-based analysis of dose distribution.. PubMed. 27(5B). 3471–6. 11 indexed citations
8.
Rocco, Bernardo, Ottavio De Cobelli, Maria E. Leon, et al.. (2006). Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report. European Urology. 49(5). 827–833. 32 indexed citations
9.
Matei, Deliu Victor, Bernardo Rocco, Fabrizio Verweij, et al.. (2005). Synchronous collecting duct carcinoma and papillary renal cell carcinoma: a case report and review of the literature.. PubMed. 25(1B). 579–86. 16 indexed citations
10.
Rocco, Bernardo, et al.. (2005). Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer.. PubMed. 25(1B). 577–8. 2 indexed citations
11.
Scardino, E., Giulia Villa, Guido Bonomo, et al.. (2004). Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology. 63(6). 1158–1162. 44 indexed citations
12.
Chinol, Marco, Ottavio De Cobelli, Giuseppe Trifirò, et al.. (2003). Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy. European Urology. 44(5). 556–559. 16 indexed citations
13.
Verweij, Fabrizio, E. Scardino, Bernardo Rocco, et al.. (2003). Late solitary thyroid carcinoma metastasis to the kidney: a case report.. PubMed. 23(1B). 561–4. 15 indexed citations
14.
Rocco, Bernardo, E. Scardino, Fabrizio Verweij, et al.. (2003). Spermatic cord liposarcoma: a report of four cases.. PubMed. 23(3C). 2933–4. 5 indexed citations
16.
17.
Scardino, E., P. Lissoni, Mariano Andrés, et al.. (1997). [Preoperative subcutaneous immunotherapy with interleukin-2 in renal carcinoma with synchronous metastasis: randomized clinico-biological study. Preoperative use of Il-2 in renal carcinoma].. PubMed. 69(1). 49–54.
18.
Lissoni, Paolo, Sandro Barni, Antonio Ardizzoia, et al.. (1994). Prognostic Factors of the Clinical Response to Subcutaneous Immunotherapy with lnterleukin-2 Alone in Patients with Metastatic Renal Cell Carcinoma. Oncology. 51(1). 59–62. 38 indexed citations
20.
Cobelli, Ottavio De, et al.. (1989). [Prognostic parameters in extracorporeal lithotripsy].. PubMed. 61(4). 361–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026